Finance entity
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention BioLargo, Inc., the most common co-covered peer. Source depth averages 5 original sources per story, versus 2.5 across the same-window beat baseline.
Last mentioned: Mar 9, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention BioLargo, Inc., the most common co-covered peer. Source depth averages 5 original sources per story, versus 2.5 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 6.6 for that window. We currently track 1 Finance story that mention Ryan Coleman, all published on March 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 92 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Ryan Coleman. Shared-story counts are live from our verified record — not editorial picks.
A series of Q4 2025 earnings reports from emerging technology and biotech firms reveal significant bottom-line misses, led by a substantial shortfall from long-duration energy storage provider ESS Tech. The results underscore the ongoing challenges for growth-stage companies in balancing heavy R&D investment with path-to-profitability expectations.
Ryan Coleman is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
